Concepedia

Carleton R. Sage

CR

Statistics

Publications

27

Citations

1.1K

H-Index

22

Active since

1993

Affiliations

Arena Pharmaceuticals (United States)(Current)

University of California, San Francisco

University of California, Santa Barbara

Merck & Co., Inc., Rahway, NJ, USA (United States)

Johnson & Johnson (United States)

Carleton R. Sage is an author at Arena Pharmaceuticals (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1993–2017

27

Publications

27

3-(1<i>H</i>-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2008 · 96 citations · Full text

, , +14

1-Alkyl-benzotriazole-5-carboxylic Acids Are Highly Selective Agonists of the Human Orphan G-Protein-Coupled Receptor GPR109b

Graeme Semple, Philip J. Skinner, Martin C. Cherrier et al. · Journal of Medicinal Chemistry · 2006 · 80 citations · Full text

, , +17

The additivity of substrate fragments in enzyme–ligand binding

Thomas J. Stout, Carleton R. Sage, Robert M. Stroud · Structure · 1998 · 77 citations · Full text

, , +14

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 72 citations · Full text

, , +17

Microtubule Dynamics Modulated by Guanosine Triphosphate Hydrolysis Activity of β-Tubulin

Ashley Davis, Carleton R. Sage, Cynthia A. Dougherty et al. · Science · 1994 · 72 citations

, , +14

1–5 of 27